[District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine]

T Denolle1, Y Eon, H Le Néel

  • 1Hôpital Dinard et Biotrial Rennes. denolle.thierry@wanadoo.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|October 14, 2005
PubMed

Insights

This study shows that while a health program improved hypertension management feasibility, resistant hypertension treatment remains insufficient. Self-blood pressure measurement (SBPM) is crucial for accurate hypertension control assessment.

Area of Science:

  • Cardiology
  • General Medicine
  • Hypertension Management

Background:

  • Resistant hypertension poses a significant cardiovascular risk.
  • Current general practice management of hypertension may be insufficient.
  • French hypertension recommendations aim to improve patient outcomes.

Purpose of the Study:

  • To assess the feasibility of improving cardiovascular risk in resistant hypertensive patients.
  • To evaluate the effectiveness of French hypertension recommendations in a general medicine setting.
  • To analyze the impact of a structured health program on hypertension management.

Main Methods:

  • Inclusion of 191 resistant hypertensive patients managed by 170 general practitioners (GPs).
  • Utilized validated blood pressure (BP) devices for both GP and self-BP measurement (SBPM).
  • Specialist consultations, ECG, echocardiography, and vascular assessments were performed.
  • Treatment modifications were made for confirmed resistant hypertension cases.
  • Follow-up assessments occurred after four months.

Main Results:

  • Initial GP automated BP measurement reclassified 27% of patients as controlled.
  • Only 6% of resistant hypertensive patients achieved control via SBPM at home.
  • Masked hypertension was identified in 62% of controlled patients during GP consultations.
  • Cholesterol and BMI remained unchanged; smoking cessation improved in 48%.
  • Coronary risk decreased from 16.5% to 13.8% using Anderson's model.

Conclusions:

  • The health program demonstrated feasibility and good GP participation.
  • Treatment of resistant hypertension and associated risk factors remains inadequate.
  • Validated automated BP devices and SBPM are essential for accurate hypertension classification and management.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.